Q32 Bio's corporate mission is to transform the lives of patients suffering from severe autoimmune and inflammatory diseases through the discovery, clinical development, and commercialization of innovative biological therapies that successfully rebalance and restore normal immune system function. The organization is driven by a team of immunologists and drug developers committed to addressing significant medical needs where conventional treatments are inadequate.